SIRT4 and metabolic dysfunction-associated steatotic liver disease: In the article titled “Circulating Levels of Sirtuin 4, a Potential Marker of Oxidative Metabolism, Related to Coronary Artery Disease in Obese Patients Suffering from NAFLD, with Normal or Slightly Increased Liver Enzymes” [1], the second author, Carmine Finelli, is not affiliated to the Stella Maris Mediterraneum Foundation and should be listed as an independent researcher.